Age-related loss of CpG methylation in the tumour necrosis factor promoter

Cytokine

Volumn 56, Issue 3, 2011, Pages 792-797

  Gowers, Isobel R ^a   Walters, Kevin ^a   Kiss Toth, Endre ^a   Read, Robert C ^a   Duff, Gordon W ^a   Wilson, Anthony G ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Age; DNA methylation; Epigenetics; Expression; TNF

Indexed keywords

DNA; TUMOR NECROSIS FACTOR;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CPG GENE; CPG ISLAND; CYTOKINE PRODUCTION; DEMETHYLATION; DNA METHYLATION; GENE; GENE ACTIVITY; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE LOSS; GENE SEQUENCE; HUMAN; HUMAN CELL; LEUKOCYTE; MACROPHAGE; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING; REPORTER GENE; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; TUMOR NECROSIS FACTOR GENE;

ADULT; AGING; CONSENSUS SEQUENCE; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENES, REPORTER; HUMANS; MACROPHAGES; MALE; NUCLEOTIDE MOTIFS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 81455131478     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.09.009     Document Type: Article

References (36)

1. Beutler B., Cerami A. The biology of cachectin/TNF-a primary mediator of the host response. Ann Rev Immunol 1989, 7:625-655.
2. Kwiatkowski D., Hill A.V.S., Sambou I., Twumasi P., Castracane J., Manogue K.R., et al. TNF concentrations in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 1990, 336:1201-1204.
3. Waage A., Halstensen A., Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987, 1:355-357.
4. D'Haens G., Van Deventer S., Van Hogezand R., Chalmers D., Kothe C., Baert F., et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. Gastroenterology 1999, 116:1029-1034.
5. Elliott M.J., Maini R.N., Feldmann M., Long-Fox A., Charles P., Katsikis P., et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor a. Arthritis Rheum 1993, 36:1681-1690.
6. Sariban E., Imamura K., Leubbers R., Kufe D. Transcriptional and post-transcriptional regulation of tumor necrosis factor gene expression in human monocytes. J Clin Invest 1988, 81:1506-1510.
7. Goldfeld A.E., Strominger J.L., Doyle C. Human tumor necrosis factor a gene regulation in phorbol ester stimulated T and B cell lines. J Exp Med 1991, 174:73-81.
8. Goldfeld A.E., Doyle C., Maniatis T. Human tumor necrosis factor a gene regulation by virus and lipopolysaccharide. Proc Natl Acad Sci USA 1990, 87:9769-9773.
9. Jacob C.O., Fronek Z., Lewis G.D., Koo M., Hansen J.A., McDevitt H.O. Heritable major histocompatibility complex class II-associated differences in production of tumour necrosis factor a: Relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990, 87:1233-1237.
10. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997, 94:3195-3199.
11. Knight J.C., Udalova I., Hill A.V.S., Greenwood B.M., Peshu N., Marsh K., et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999, 22:145-150.
12. De Martinis M., Franceschi C., Monti D., Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett 2005, 579:2035-2039.
13. Fagnoni F.F., Vescovini R., Passeri G., Bologna G., Pedrazzoni M., Lavagetto G., et al. Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood 2000, 95:2860-2868.
14. Xu X., Beckman I., Ahern M., Bradley J. A comprehensive analysis of peripheral blood lymphocytes in healthy aged humans by flow cytometry. Immunol Cell Biol 1993, 71(Pt 6):549-557.
15. O'Mahony L., Holland J., Jackson J., Feighery C., Hennessy T.P., Mealy K. Quantitative intracellular cytokine measurement: age-related changes in pro-inflammatory cytokine production. Clin Exp Immunol 1998, 113:213-219.
16. Fagiolo U., Cossarizza A., Scala E., Fanales-Belasio E., Ortolani C., Cozzi E., et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 1993, 23:2375-2378.
17. van Duin D., Mohanty S., Thomas V., Ginter S., Montgomery R.R., Fikrig E., et al. Age-associated defect in human TLR-1/2 function. J Immunol 2007, 178:970-975.
18. Bjornsson H.T., Sigurdsson M.I., Fallin M.D., Irizarry R.A., Aspelund T., Cui H., et al. Intra-individual change over time in DNA methylation with familial clustering. JAMA 2008, 299:2877-2883.
19. Eckhardt F., Lewin J., Cortese R., Rakyan V.K., Attwood J., Burger M., et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 2006, 38:1378-1385.
20. Li G., Weyand C.M., Goronzy J.J. Epigenetic mechanisms of age-dependent KIR2DL4 expression in T cells. J Leukoc Biol 2008, 84:824-834.
21. Marinou I., Montgomery D.S., Dickson M.C., Binks M.H., Moore D.J., Bax D.E., et al. The Interferon-induced helicase domain 1 A946G polymorphism is not associated with rheumatoid arthritis. Arthritis Res Ther 2007, 9:R40.
22. Mewar D., Marinou I., Lee M.E., Timms J.M., Kilding R., Teare M.D., et al. Haplotype-specific gene expression profiles in a telomeric major histocompatibility complex gene cluster and susceptibility to autoimmune diseases. Genes Immun 2006, 7:625-631.
23. Gomez C.R., Boehmer E.D., Kovacs E.J. The aging innate immune system. Curr Opin Immunol 2005, 17:457-462.
24. Cutolo M., Montecucco C.M., Cavagna L., Caporali R., Capellino S., Montagna P., et al. Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. Ann Rheum Dis 2006, 65:1438-1443.
25. Feldmann M., Brennan F.M., Maini R.N. Rheumatoid arthritis. Cell 1996, 85:307-310.
26. Petronis A. Human morbid genetics revisited: relevance of epigenetics. Trends Genet 2001, 17:142-146.
27. Doran M.F., Pond G.R., Crowson C.S., O'Fallon W.M., Gabriel S.E. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 2002, 46:625-631.
28. Sarter B., Long T.I., Tsong W.H., Koh W.P., Yu M.C., Laird P.W. Sex differential in methylation patterns of selected genes in Singapore Chinese. Hum Genet 2005, 117:402-403.
29. Golbus J., Palella T.D., Richardson B.C. Quantitative changes in T cell DNA methylation occur during differentiation and ageing. Eur J Immunol 1990, 20:1869-1872.
30. Wilson V.L., Jones P.A. DNA methylation decreases in aging but not in immortal cells. Science 1983, 220:1055-1057.
31. Fraga M.F., Ballestar E., Paz M.F., Ropero S., Setien F., Ballestar M.L., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 2005, 102:10604-10609.
32. Christensen B.C., Houseman E.A., Marsit C.J., Zheng S., Wrensch M.R., Wiemels J.L., et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 2009, 5:e1000602.
33. Lopatina N., Haskell J.F., Andrews L.G., Poole J.C., Saldanha S., Tollefsbol T. Differential maintenance and de novo methylating activity by three DNA methyltransferases in aging and immortalized fibroblasts. J Cell Biochem 2002, 84:324-334.
34. Valinluck V., Sowers L.C. Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers. Cancer Res 2007, 67:5583-5586.
35. Williams K., Christensen J., Pedersen M.T., Johansen J.V., Cloos P.A., Rappsilber J., et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011, 473:343-348.
36. Maxwell J.R., Potter C., Hyrich K.L., Barton A., Worthington J., Isaacs J.D., et al. Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis. Hum Mol Genet 2008, 17:3532-3538.